SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-19-017031
Filing Date
2019-11-13
Accepted
2019-11-13 16:06:40
Documents
46
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 867015
2 ex31-1.htm EX-31.1 10873
3 ex31-2.htm EX-31.2 10771
4 ex32-1.htm EX-32.1 6706
5 ex32-2.htm EX-32.2 6700
  Complete submission text file 0001493152-19-017031.txt   3880764

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE owcp-20190930.xml EX-101.INS 680316
7 XBRL SCHEMA FILE owcp-20190930.xsd EX-101.SCH 54918
8 XBRL CALCULATION FILE owcp-20190930_cal.xml EX-101.CAL 43803
9 XBRL DEFINITION FILE owcp-20190930_def.xml EX-101.DEF 145723
10 XBRL LABEL FILE owcp-20190930_lab.xml EX-101.LAB 348785
11 XBRL PRESENTATION FILE owcp-20190930_pre.xml EX-101.PRE 224811
Mailing Address 2 BEN GURION ST. B.S.R BUILDING#1, FLOOR#7, RAMAT GAN L3 5257334
Business Address 2 BEN GURION ST. B.S.R BUILDING#1, FLOOR#7, RAMAT GAN L3 5257334 972-72-2608004
OWC Pharmaceutical Research Corp. (Filer) CIK: 0001431934 (see all company filings)

IRS No.: 980573566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54856 | Film No.: 191213990
SIC: 3841 Surgical & Medical Instruments & Apparatus